Braden Michael Leonard - Apr 11, 2022 Form 4 Insider Report for Gemini Therapeutics, Inc. /DE (IRON)

Role
10%+ Owner
Signature
Braden Michael Leonard
Stock symbol
IRON
Transactions as of
Apr 11, 2022
Transactions value $
$1,337,929
Form type
4
Date filed
4/13/2022, 04:09 PM
Next filing
Apr 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRON Common Stock Purchase $75.1K +55K +25.58% $1.37* 270K Apr 12, 2022 Direct F2
transaction IRON Common Stock Purchase $681K +504K +12.3% $1.35* 4.6M Apr 11, 2022 Holding of BML Investment Partners, L.P.(1) F1, F3
transaction IRON Common Stock Purchase $290K +204K +4.42% $1.42* 4.81M Apr 12, 2022 Holding of BML Investment Partners, L.P.(1) F1, F4
transaction IRON Common Stock Purchase $292K +192K +3.99% $1.52* 5M Apr 13, 2022 Holding of BML Investment Partners, L.P.(1) F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Explanation of Responses: 1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.355 to $1.40. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.3496 to $1.35. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.35 to $1.45. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
F5 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.60. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.